Should drug prices be negotiated under part D of Medicare? And if so, how?

Health Affairs
Richard G Frank, Joseph P Newhouse

Abstract

Medicare's Part D prescription drug benefit has offered affordable coverage to millions of elderly Americans since its January 2006 implementation. A great deal of concern has been expressed about whether drugs are being purchased in a cost-effective manner. Many believe that the government should be negotiating prices with pharmaceutical manufacturers. We look at prescription drug pricing under Part D by examining the logic behind existing arrangements and by reviewing initial evidence on the behavior of prices. We make a modest proposal for how to improve purchasing of prescription drugs in Medicare.

References

Mar 9, 2004·Health Affairs·Joseph P Newhouse
Jun 23, 2007·Inquiry : a Journal of Medical Care Organization, Provision and Financing·Joseph P NewhouseRichard G Frank

❮ Previous
Next ❯

Citations

Jun 27, 2008·Journal of General Internal Medicine·Walid F GelladJennifer S Haas
Feb 5, 2010·Health Economics, Policy, and Law·Kalipso ChalkidouRuth Faden
Feb 9, 2008·Nature Biotechnology
Jul 25, 2009·The New England Journal of Medicine·Patricia Neuman, Juliette Cubanski
Sep 2, 2011·The New England Journal of Medicine·Lisa Clemans-Cope, Timothy Waidmann
Oct 15, 2011·The New England Journal of Medicine·Richard G Frank
May 6, 2009·Health Affairs·Julie M DonohueSamuel H Zuvekas
Mar 7, 2009·Journal of the American Board of Family Medicine : JABFM·Nancy E MordenStephen J Bartels
May 11, 2010·Journal of Public Economics·Darius Lakdawalla, Neeraj Sood
Dec 20, 2008·The Journal of Law, Medicine & Ethics : a Journal of the American Society of Law, Medicine & Ethics·Bruce SiegelRobert Burke
Dec 11, 2014·Health Economics·David B Ridley
Feb 27, 2015·Health Policy·Francesco Decarolis
May 6, 2015·The Review of Economics and Statistics·Darius Lakdawalla, Wesley Yin
Aug 15, 2017·Pharmacotherapy·G Caleb AlexanderGerard Anderson
Aug 1, 2009·Health Affairs·Kevin Outterson, Aaron S Kesselheim
Jan 15, 2019·JAMA Internal Medicine·Francis J Crosson, Jon B Christianson
Jan 31, 2009·American Journal of Health-system Pharmacy : AJHP : Official Journal of the American Society of Health-System Pharmacists·James M HoffmanGlen T Schumock
Mar 16, 2017·Nature Reviews. Clinical Oncology·Vinay PrasadSham Mailankody
Nov 12, 2019·Annals of Internal Medicine·Hilary DanielUNKNOWN Health Public Policy Committee of the American College of Physicians
Oct 8, 2019·JAMA : the Journal of the American Medical Association·William H ShrankNatasha Parekh
Oct 14, 2017·Journal of Pharmaceutical Policy and Practice·Jeromie BallreichGerard Anderson
Oct 6, 2009·Applied Health Economics and Health Policy·William E Encinosa
Apr 1, 2015·The American Economic Review·Francesco Decarolis

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.